Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ⅰ Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of GEN-725 Tablets in Patients With Advanced Solid Tumors

NCT07229898 is registered in ClinicalTrials.gov with Henan Genuine Biotech Co., Ltd. as lead sponsor.

NCT NCT07229898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07229898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ⅰ Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of GEN-725 Tablets in Patients With Advanced Solid Tumors
Lead sponsor
Henan Genuine Biotech Co., Ltd.
Phase
Phase 1
Overall status
Recruiting
Start date
January 7, 2025
Completion date
December 31, 2026
Enrollment
48 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors